Weekly Report – Global Liquidity & Strategic Transactions – August 18–24, 2025 

The week of August 18–24 confirmed the transition toward selective capital deployment. While M&A momentum held firm, credit markets revealed signs of stress under tighter regulatory oversight. Global equity sentiment was shaped by central bank signals, with divergent trajectories between the U.S. and Europe. Institutional investors remained highly tactical, privileging resilient assets and cross-border opportunities. 

Macro Outlook & Market Flows 

• Federal Reserve tone: Minutes released on August 21 indicated openness to a September rate cut, citing slowing labor data. U.S. equities rallied mid-week, while Treasury yields fell to 3.9%, their lowest since April. 

• European Central Bank (ECB): Christine Lagarde reiterated on August 20 that rate reductions will remain gradual, stressing “patience against premature easing.” The euro weakened slightly (–2.1% vs. USD), reversing part of its YTD gains. 

• Emerging Markets: According to Reuters (Aug 22), sovereign bonds from Brazil and Mexico saw record inflows, driven by carry trade dynamics and stable commodity prices. 

• Energy Markets: Crude stabilized around USD 74/bbl, after the prior week’s selloff. Saudi Arabia reaffirmed supply discipline, tempering volatility. 

Summary: Markets oscillated between U.S. dovish expectations and ECB caution, reinforcing the case for global diversification and positioning toward high-yield EM debt. 

M&A: Momentum in Cross-Border Transactions 

• Healthcare consolidation: Pfizer announced the USD 18.6 billion acquisition of a Swiss biotech firm focused on rare diseases (FT, Aug 19). 

• Technology & AI: Bloomberg (Aug 20) reported Microsoft’s minority stake in a Japanese robotics company valued at USD 6.2 billion, strengthening its Asia-Pacific footprint. 

• Infrastructure: A consortium led by Macquarie finalized the purchase of Spain’s Red Eléctrica fiber unit for USD 3.8 billion. 

Key Insight: M&A activity is shifting toward cross-border deals in health, tech, and infrastructure—sectors aligned with long-term secular growth. 

Private Credit: Regulatory Heat & Capital Repositioning 

• Axios (Aug 21) noted that the SEC intensified reviews of disclosure practices in direct lending funds, raising compliance costs. 

• Fundraising lag persists: only USD 85 billion YTD, compared with USD 120 billion over the same period in 2024 (Bloomberg, Aug 22). 

• Notable transaction: Apollo Global closed a USD 2.1 billion hybrid credit facility for a logistics company in Europe, illustrating demand for structured and asset-backed debt. 

Insight: Private credit remains active but is increasingly barbell-shaped—with large institutional platforms thriving, while smaller funds struggle under regulatory and fundraising pressures. 

IPOs & SPACs: Testing Market Windows 

• IPO revival: The Financial Times (Aug 23) highlighted the USD 1.4 billion IPO of an Indian EV manufacturer, oversubscribed 4.5x, underscoring strong demand in mobility and green sectors. 

• SPAC fatigue: A defense-sector SPAC backed by U.S. veterans failed to secure commitments for its USD 250 million raise (WSJ, Aug 20). 

• China tech listings: Reuters (Aug 22) reported Beijing’s approval of five semiconductor IPOs worth over USD 3.2 billion, signaling strategic prioritization despite capital controls. 

Interpretation: IPO activity is returning selectively, with green mobility and semiconductors at the forefront, while SPACs face narrowing investor appetite. 

Conclusion & Outlook for 2H 2025 

The August 18–24 window illustrates the dual track of global liquidity: M&A and selective IPOs thrive in strategic verticals, while private credit adapts under regulatory headwinds. Macro divergence between the Fed and ECB reinforces the importance of multi-region hedging. Institutional investors are expected to double down on defensive but growth-aligned plays, particularly in healthcare, AI, and energy transition. 

Executive Summary 

CATEGORY	KEY FINDINGS	STRATEGIC IMPERATIVE
M&A	Cross-border megadeals in healthcare, tech, and infrastructure.	Leverage secular growth via international consolidation.
Private Credit	Regulatory scrutiny rising; fundraising slowing.	Focus on scale players and structured debt.
IPOs / SPACs	IPOs in EVs and semiconductors show strength; SPACs faltering.	Target green & strategic tech; avoid speculative SPACs.
Macro & Flows	Fed dovish signals vs. ECB caution; EM debt inflows surge.	Position in EM carry and global multi-asset hedges.